Geert de Vreede
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Geert de Vreede has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- David Bilder
Department of Molecular and Cell Biology, University of California-Berkeley, Berkeley, CA 94720, USA
2 shared publications - Stephan U. Gerlach
Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
2 shared publications
Latest Publications
- Open Access
- 10 November 2022
- Published by The Company of Biologists in Biology Open
- Vol. 11 (11)
PTP10D-mediated cell competition is not obligately required for elimination of polarity-deficient clones
Animal organs maintain tissue integrity and ensure removal of aberrant cells through several types of surveillance mechanisms. One prominent example is the elimination of polarity-deficient mutant cells within developing Drosophila imaginal discs. This has been proposed to require heterotypic cell competition dependent on the receptor tyrosine phosphatase PTP10D within the mutant cells. We report here experiments to test this requirement in various contexts and find that PTP10D is not obligately required for the removal of scribble (scrib) mutant and similar polarity-deficient cells. Our experiments used identical stocks with which another group can detect the PTP10D requirement, and our results do not vary under several husbandry conditions including high and low protein food diets. Although we are unable to identify the source of the discrepant results, we suggest that the role of PTP10D in polarity-deficient cell elimination may not be absolute.
- 10 November 2022
- Published by The Company of Biologists in Biology Open
- Vol. 11 (11)
Open AccessPTP10D-mediated cell competition is not obligately required for elimination of polarity-deficient clones
Animal organs maintain tissue integrity and ensure removal of aberrant cells through several types of surveillance mechanisms. One prominent example is the elimination of polarity-deficient mutant cells within developing Drosophila imaginal discs. This has been proposed to require heterotypic cell competition dependent on the receptor tyrosine phosphatase PTP10D within the mutant cells. We report here experiments to test this requirement in various contexts and find that PTP10D is not obligately required for the removal of scribble (scrib) mutant and similar polarity-deficient cells. Our experiments used identical stocks with which another group can detect the PTP10D requirement, and our results do not vary under several husbandry conditions including high and low protein food diets. Although we are unable to identify the source of the discrepant results, we suggest that the role of PTP10D in polarity-deficient cell elimination may not be absolute.
- 14 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6590) , 297-301
Epithelial monitoring through ligand-receptor segregation ensures malignant cell elimination
Animals have evolved mechanisms, such as cell competition, to remove dangerous or nonfunctional cells from a tissue. Tumor necrosis factor signaling can eliminate clonal malignancies from Drosophila imaginal epithelia, but why this pathway is activated in tumor cells but not normal tissue is unknown. We show that the ligand that drives elimination is present in basolateral circulation but remains latent because it is spatially segregated from its apically localized receptor. Polarity defects associated with malignant transformation cause receptor mislocalization, allowing ligand binding and subsequent apoptotic signaling. This process occurs irrespective of the neighboring cells’ genotype and is thus distinct from cell competition. Related phenomena at epithelial wound sites are required for efficient repair. This mechanism of polarized compartmentalization of ligand and receptor can generally monitor epithelial integrity to promote tissue homeostasis.
- 14 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6590) , 297-301
Epithelial monitoring through ligand-receptor segregation ensures malignant cell elimination
Animals have evolved mechanisms, such as cell competition, to remove dangerous or nonfunctional cells from a tissue. Tumor necrosis factor signaling can eliminate clonal malignancies from Drosophila imaginal epithelia, but why this pathway is activated in tumor cells but not normal tissue is unknown. We show that the ligand that drives elimination is present in basolateral circulation but remains latent because it is spatially segregated from its apically localized receptor. Polarity defects associated with malignant transformation cause receptor mislocalization, allowing ligand binding and subsequent apoptotic signaling. This process occurs irrespective of the neighboring cells’ genotype and is thus distinct from cell competition. Related phenomena at epithelial wound sites are required for efficient repair. This mechanism of polarized compartmentalization of ligand and receptor can generally monitor epithelial integrity to promote tissue homeostasis.